Microbiota-guided radiation therapy for head and neck cancer
Part of Cancer, Mouth & dental clinical trials.
This trial is testing a new way to use radiation therapy for head and neck cancer by also looking at the bacteria in your mouth and gut. The goal is to see if adjusting the treatment based on your bacteria can improve outcomes and reduce side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older.
- You are able to carry out daily activities with little to no help (ECOG 0–3).
- You have a type of head and neck cancer (like mouth, throat, voice box, or sinus cancer) that has not spread to other parts of the body.
- You have not had radiation therapy to the head or neck before.
- You do not have a connective tissue disease (like lupus or scleroderma).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new way of giving radiation therapy, called adaptive radiation boost, for people with head and neck cancer. The goal is to see if this approach can better target the cancer and possibly improve outcomes.
This trial tests a precise type of radiation called stereotactic radiosurgery for people with head or neck tumors. It may be an option for those who need radiation or chemoradiation as their main treatment or after surgery.
This trial tests a new way to give radiation therapy for head and neck cancer. By using a special PET scan to guide where higher radiation doses are given, doctors hope to improve treatment while reducing side effects. It is for people whose cancer is not early-stage and who will receive standard radiation therapy.
This trial tests whether giving radiation therapy in a specific way (compartmentalized) after surgery for head and neck cancer is safe and effective. It is for people with certain types of head and neck cancer that have been removed, and aims to improve outcomes while managing side effects.
This trial tests a new way to guide radiation treatment for a type of throat cancer that is on one side only. The goal is to see if using a special scan (SPECT-CT) to map lymph drainage can help doctors decide how to treat the neck more precisely and reduce side effects.
This trial tests a personalized radiotherapy approach after a few rounds of chemo-immunotherapy for people with HPV-negative head and neck cancer. It aims to adjust the radiation dose based on how the tumor responds, possibly reducing side effects while still controlling the cancer.
Hear when a new Head and Neck Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.